Although the proportion of patients with postoperative CEA elevation and no high-risk factors is low, they should still be considered as high-risk factors to guide adjuvant chemotherapy after surgery for stage II colon cancer. This evidence concerns the gene CEACAM5 and malignant colon neoplasm.